Main menu
Oxford Nanopore at ASHG 2025
14 - 18 October 2025 EDT
Boston, Massachusetts, United States

Oxford Nanopore at ASHG 2025

Oxford Nanopore will be at Booth 619 in the exhibit hall at the American Society for Human Genetics Annual Meeting in October, 2025, hosted in Boston. We will also host CoLabs, on-booth activities, an off-site reception, and an Industry Education Session on Thursday, October 16. Details to come.

Register for Oxford Nanopore activities at ASHG 2025
boston-color-2

Industry Education Session

Sequencing from large scale to single cell – the new era of biological discovery

Location: Room 153 ABC

Date: Thursday, October 16th

Time: 12:00 pm — 1:00 pm EDT

Join our Industry workshop to explore how human genetics is being transformed by the unrestricted read lengths from Oxford Nanopore sequencing technology, from understanding variant function in complex disorders to characterising hidden variants in rare disease samples. Discover how the technology captures comprehensive genomic variation, including structural variants, repeat expansions, and epigenetic modifications, and deciphers complex gene expression landscapes through characterising full-length RNA isoforms. Learn how the latest applications of Oxford Nanopore sequencing are accessing previously difficult-to-sequence genomic regions and revealing the true diversity of the transcriptome.

Agenda

Agenda

12:00 pm - 1:00 pm EDT

Talk title

Speaker

12:00 pm - 12:05 pm

Welcome and introductions

Cora Vacher, Oxford Nanopore Technologies

12:05 pm - 12:20 pm

Uncovering Alzheimer's disease-specific isoform diversity through single-cell long-read transcriptomics

Lindsay Rizzardi, University of Alabama at Birmingham

12:25 pm -12:40 pm

Enhanced hereditary cancer screening through scalable parent-of-origin-aware genomic analysis

Kasmintan Schrader, BC Cancer

12:45 pm - 1:00 pm

Capturing unaltered insights with Oxford Nanopore Sequencing

Rosemary Dokos, Oxford Nanopore Technologies

Speakers

picture of Cora Vacher

Welcome and introductions

Cora Vacher, Associate Director, Market Segment, Oxford Nanopore Technologies

Cora Vacher is the Market Segment Associate Director for Human Genetic at Oxford Nanopore Technologi...

picture of Lindsay Rizzardi

Uncovering Alzheimer's disease-specific isoform diversity through single-cell long-read transcriptomics

Lindsay Rizzardi, Assistant Professor, University of Alabama at Birmingham

Dr. Rizzardi is an Assistant Professor at the University of Alabama at Birmingham, with extensive tr...

picture of Rosemary Sinclair Dokos

Capturing unaltered insights with Oxford Nanopore Sequencing

Rosemary Sinclair Dokos, Chief Product and Marketing Officer, Oxford Nanopore Technologies

Rosemary Sinclair Dokos, Chief Product and Marketing Officer, joined Oxford Nanopore in January 2014...

picture of Kasmintan Schrader

Enhanced hereditary cancer screening through scalable parent-of-origin-aware genomic analysis

Kasmintan Schrader, Scientist and Staff Physician, co-Medical Director - Provincial Hereditary Cancer Program, BC Cancer

Dr. Kasmintan Schrader, a Clinician-Scientist, Medical Geneticist, received her PhD in Pathology and...

CoLabs

Oxford Nanopore will be hosting two CoLabs at the ASHG 2025 annual meeting. CoLabs are 30-minute sessions hosted in the exhibit hall to showcase offerings from our industry experts and thought leaders. View session details below and register to attend.

Wednesday, October 15th

From maps to mechanism: Unlocking the dynamic regulatory role of RNA modifications using single-molecule, direct RNA sequencing

Location: CoLab Theater 2

Time: 2:30 pm — 3:00 pm EDT

Oxford Nanopore Technologies provides the only technology capable of sequencing native RNA and simultaneously reading a growing list of RNA modifications – including m6A, pseudouridine and inosine. Direct RNA sequencing has other advantages like measuring polyA tail length and being free of PCR bias. Join our colab to hear from Dr Leyland Taylor, NIH, on his work to unravel the dynamic regulatory role of multiple RNA modifications in Type 2 diabetes with the goal of mapping epitranscriptomic regulation back to unexplained GWAS hits. You’ll also hear from Oxford Nanopore on the latest updates to direct RNA sequencing and RNA modification calling.

Thursday, October 16th

Known unknowns: resolving complex genomic regions with targeted sequencing

Location: CoLab Theater 1

Time: 3:15 – 3:45 PM EDT

Single nucleotide variants (SNVs) and small insertions and deletions (indels) have been the mainstay of variant analysis in sequencing based human genomics studies. However, identifying and measuring genetic variability within repetitive and structurally complex regions of the genome remains a significant challenge. Segmental duplications, high sequence homology between paralogues, and repetitive regions are a few of the challenges facing all DNA sequencing technologies in terms of sequence alignment, variant calling and interpretation. Oxford Nanopore sequencing provides the means to interrogate these challenging loci and resolve numerous challenging medically relevant genes (CMRGs) through targeted sequencing. Join our Colabs for an update on compatible methods and how to select the best fit to your requirements.

On-booth activities

Booth 619

Wednesday, October 15

Thursday, October 16

Friday, October 17

10:15 am— ​​Data for breakfast: Solving the most complex genetic architectures with state-of-the-art de novo assembly

Sean McKenzie, Director, Applications Bioinformatics

10:15 am— Data for breakfast: EPI2ME updates - Oxford Nanopore Technologies' comprehensive analysis platform

Matt Parker, Director, Clinical Bioinformatics Software

10:15 am— A tour of the dark genome

Lynn Ly, Genomic Applications Bioinformatician

11:45 am— Resolving complex haplotypes in pharmacogenomic genes

Carly Tyer, Applications Scientist

11:45 am— A tour of the dark genome

Lynn Ly, Genomic Applications Bioinformatician

11:45 am— Resolving complex haplotypes in pharmacogenomic genes

Carly Tyer, Applications Scientist

12:45 pm— ElysION: from sample to analysis, end-to-end nanopore sequencing on a single device

Steph Wilbraham, Director, Product Management

12:45 pm— ElysION: from sample to analysis, end-to-end nanopore sequencing on a single device

Steph Wilbraham, Director, Product Management

2:45 pm — Multiomic data in one run: flow cell loading and sequencing setup

Subhoshree Ghose, Field Applications Scientist

2:45 pm — Multiomic data in one run: flow cell loading and sequencing setup

Subhoshree Ghose, Field Applications Scientist

2:45 pm — Multiomic data in one run: flow cell loading and sequencing setup

Subhoshree Ghose, Field Applications Scientist

3:45 pm— Title TBC

Dan Fordham, Director, Strategic Product Management

3:45 pm— ElysION: from sample to analysis, end-to-end nanopore sequencing on a single device

Steph Wilbraham, Director, Product Management

Reception

Join Oxford Nanopore team and other nanopore users at Carrie Nation Cocktail Club to chat about current applications of our technology!

Time: 8:00 pm ~ 12:00 am EDT

Date: Thursday, October 16

Venue: Carrie Nation Cocktail Club

Location: 11 Beacon St, Boston, MA 02108

Please note, this event will be first-come, first-served. You will need an ASHG badge to attend the reception. Attendees must be age 21+.

CarrieNation

Register

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

联系我们

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

关于 Oxford Nanopore

Contact us 领导团队 媒体资源和联系方式 投资者 在 Oxford Nanopore 工作 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag